Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China flag China · Delayed Price · Currency is CNY
65.91
+0.29 (0.44%)
At close: Mar 6, 2026

Hangzhou Alltest Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,1615,0034,9095,3625,5196,631
Market Cap Growth
-5.99%1.91%-8.43%-2.86%-16.76%-
Enterprise Value
2,7102,5522,2592,6482,0034,130
Last Close Price
65.9163.8961.0062.7558.2866.65
PE Ratio
23.9722.9216.2329.694.668.66
PS Ratio
5.665.495.677.101.633.54
PB Ratio
1.321.281.261.401.322.03
P/TBV Ratio
1.371.331.301.441.362.04
P/FCF Ratio
--45.10-5.068.46
P/OCF Ratio
--14.90216.514.067.18
EV/Sales Ratio
2.972.802.613.510.592.21
EV/EBITDA Ratio
9.849.268.4822.031.454.88
EV/EBIT Ratio
10.8510.229.3926.741.484.93
EV/FCF Ratio
--20.75-1.845.27
Debt / Equity Ratio
0.000.000.000.010.010.01
Debt / EBITDA Ratio
0.030.030.020.170.020.04
Debt / FCF Ratio
--0.04-0.020.05
Net Debt / Equity Ratio
-0.63-0.63-0.66-0.72-0.91-0.89
Net Debt / EBITDA Ratio
-8.89-8.89-9.66-23.01-2.75-3.45
Net Debt / FCF Ratio
---23.645.44-3.48-3.73
Asset Turnover
--0.210.170.780.73
Inventory Turnover
--2.251.995.413.33
Quick Ratio
--9.0610.577.764.53
Current Ratio
--9.9111.538.205.14
Return on Equity (ROE)
5.61%5.61%7.85%4.51%31.85%36.06%
Return on Assets (ROA)
--3.62%1.41%19.45%20.29%
Return on Invested Capital (ROIC)
15.08%15.85%17.64%12.52%318.80%216.75%
Return on Capital Employed (ROCE)
--6.20%2.60%32.40%25.40%
Earnings Yield
4.23%4.36%6.16%3.37%21.47%11.55%
FCF Yield
--2.22%-9.49%19.76%11.82%
Dividend Yield
3.03%-4.92%2.39%11.59%4.06%
Payout Ratio
--76.92%292.78%18.20%14.08%
Buyback Yield / Dilution
-0.24%-0.24%0.02%0.07%-5.96%-25.16%
Total Shareholder Return
2.80%-0.24%4.94%2.46%5.63%-21.10%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.